Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Dalcetrapib by DalCor Pharmaceuticals for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Dalcetrapib is under clinical development by DalCor Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to...